Management of dental extraction in patients with haemophilia A and B: A report of 58 extractions
作者： A. Peisker , GF. Raschke , S. Schultze-Mosgau
关键词:
摘要: Objectives: Patients with inherited bleeding disorders are at high risk of following oral surgery and present challenges to the surgeons. Aim this study was report our experience in dental extraction patients exhibiting Haemophilia A B between 2007 2012. Patient Methods: 58 extractions 15 during 19 interventions were performed. Replacement therapy recombinant plasma-derived factor VIII IX applied systematically combination antifibrinolytic treatment local haemostatic measures. The data recorded: type surgery, measures, general substitution, systemic agents occurrence post operative complications. Results: Two presented postoperative bleeding. One had secondary requiring additional injection concentrates. other one epistaxis which managed conservatively a nasal tamponade. Conclusions: Excellent haemostasis is achievable after by protocol using defined pre- doses concentrates
unirioja.es
core.ac.uk
sci-hub.se 参考文章(30)
R Schwaab, H-H Brackmann, C Meyer, J Seehafer, M Kirchgesser, A Haack, K Olek, E G D Tuddenham, J Oldenburg, Haemophilia A: mutation type determines risk of inhibitor formation. Thrombosis and Haemostasis. ,vol. 74, pp. 1402- 1406 ,(1995) , 10.1055/S-0038-1649954
J Oldenburg, J K Picard, R Schwaab, H H Brackmann, E G D Tuddenham, E Simpson, HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII. Thrombosis and Haemostasis. ,vol. 77, pp. 238- 242 ,(1997) , 10.1055/S-0038-1655945
Frits Rosendaal, Louis Aledort, Jeanne Lusher, Chantal Rothschild, Jørgen Ingerslev, Gilbert White, Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thrombosis and Haemostasis. ,vol. 85, pp. 560- 560 ,(2001) , 10.1055/S-0037-1615621
Pier Mannuccio Mannucci, Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years Blood. ,vol. 90, pp. 2515- 2521 ,(1997) , 10.1182/BLOOD.V90.7.2515.2515_2515_2521
ID Hewson, P Makhmaloaf, Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe haemophilia B. Australian Dental Journal. ,vol. 55, pp. 322- 324 ,(2010) , 10.1111/J.1834-7819.2010.01242.X
David Lillicrap, Caroline Hensman, Robert Card, Mary-Frances Scully, Man-Chiu Poon, , Recombinant factor IX recovery and inhibitor safety: a Canadian post-licensure surveillance study. Thrombosis and Haemostasis. ,vol. 87, pp. 431- 435 ,(2002) , 10.1055/S-0037-1613022
Ezio Zanon, Christian Bacci, Graziella Saggiorato, Barbara Brandolin, Complex dental extractions in a patient with severe haemophilia A and inhibitors treated with activated prothrombin complex concentrate. Vox Sanguinis. ,vol. 10, pp. 225- 227 ,(2012) , 10.2450/2012.0067-11
C.A. Ludlam, B.T. Colvin, F.G.H. Hill, F.E. Preston, N. Wasseem, R. Bagnall, I.R. Peake, E. Berntorp, E.P. Mauser Bunschoten, K. Fijnvandraat, C.K. Kasper, G. White, E. Santagostino, C.R.M. Hay, , Factor VIII inhibitors in mild and moderate-severity haemophilia A Thrombosis and Haemostasis. ,vol. 79, pp. 762- 766 ,(1998) , 10.1055/S-0037-1615061
Zanon, Martinelli, Bacci, Zerbinati, Girolami, Proposal of a standard approach to dental extraction in haemophilia patients. A case‐control study with good results Haemophilia. ,vol. 6, pp. 533- 536 ,(2000) , 10.1046/J.1365-2516.2000.00423.X
M. R. Jackson, M. J. MacPhee, W. N. Drohan, B. M. Alving, Fibrin sealant: current and potential clinical applications Blood Coagulation & Fibrinolysis. ,vol. 7, pp. 737- 746 ,(1996) , 10.1097/00001721-199611000-00001